tiprankstipranks
Analyst Profile
Followed by 193 other investors
.
Michelle Gilson

Michelle Gilson

Canaccord Genuity
Wall Street Analyst
Ranked #1,895 out of 8,047 Analysts on TipRanks (#3,489 out of 21,521 overall experts)

Success Rate

43%
61 out of 143 Profitable Transactions

Average Return

7.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Michelle Gilson's ratings since 2016 and opened each position for the duration of 1 Year:
42.66% of your transactions would have been profitable with an average return of 7.7%

Stock Rating Distribution

187Ratings
98.93% Buy
1.07% Hold
0.00% Sell
Distribution of Michelle Gilson's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
ChemoCentryx Inc
(CCXI)
Rating Type:Buy
Dates:Nov 25, 2019 - Nov 25, 2020
Gain:569.90%
The most profitable rating made by Michelle Gilson

Michelle Gilson's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Vertex Pharmaceuticals
Jul 13, 2016
Hold
Assigned
0.00%
1
XLRN
Acceleron Pharma
Jul 13, 2016
Buy
Assigned
0%
-3.40%
1
uniQure
Jul 27, 2016
Buy
Reiterated
$23.00
(12.86% Upside)
100%
+11.30%
1
Pieris Pharmaceuticals
Aug 11, 2016
Buy
Reiterated
$10.00
(536.94% Upside)
100%
+171.00%
1
Cellectis SA
Sep 13, 2016
Buy
Reiterated
$65.00
(1606.04% Upside)
100%
+10.30%
1
Synlogic
Sep 20, 2016
Hold
Downgraded
0%
-38.80%
2
Summit Therapeutics
Oct 06, 2016
Buy
Reiterated
$28.00
(2541.51% Upside)
67%
+72.27%
3
Sarepta Therapeutics
Oct 31, 2016
Buy
Reiterated
$76.00
(-30.28% Downside)
75%
+68.65%
8
Affimed
Nov 02, 2016
Buy
Reiterated
$19.00
(522.95% Upside)
0%
-2.30%
1
Kura Oncology
Nov 07, 2016
Buy
Reiterated
$16.00
(-1.42% Downside)
100%
+139.80%
2
List of latest recommendations made by Michelle Gilson. Click to expand and see Michelle Gilson's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More